GFAP and myeloid sarcoma: Glial fibrillary acidic protein (GFAP) is an astrocytic cytoskeletal intermediate filament protein released into the CSF and into the blood in disorders associated with astrocyte activation and astrogliosis following inflammation and neurodegeneration and therefore is highly expressed in MS lesions [31,32].